Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.

OBJECTIVE: To study whether recombinant human erythropoietin (r-hu-Epo) improves anaemia and reduces disease activity in patients with rheumatoid arthritis and anaemia of chronic disease (ACD). METHODS: A 52 week placebo controlled randomised double blind trial with r-hu-Epo was performed in 70 pati...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ann Rheum Dis
Main Authors: Peeters, H R, Jongen-Lavrencic, M, Vreugdenhil, G, Swaak, A J
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 1996
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1010292/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8984939/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.55.10.739
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker